NCT00131378View on ClinicalTrials.gov

Growth Hormone, Cardiovascular Risk, and Visceral Adiposity

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2012

Study Completion Date

June 30, 2013

Conditions
Obesity
Interventions
DRUG

Nutropin AQ growth hormone

Participants will give themselves injections of growth hormone every night for 6 months.

DRUG

Placebo Growth Hormone

Participants will give themselves injections of placebo growth hormone every night for 6 months.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00131378 - Growth Hormone, Cardiovascular Risk, and Visceral Adiposity | Biotech Hunter | Biotech Hunter